Literature DB >> 26384281

Nasal NK/T-cell lymphoma: RT, CT, or both.

Eric Tse1, Yok-Lam Kwong1.   

Abstract

In this issue of Blood, Yang et al have proposed that for early-stage nasal type natural killer (NK)/T-cell lymphoma, combined radiotherapy (RT), and chemotherapy (CT) improve survival, but CT can be safely omitted in certain low-risk patients treated with RT.

Entities:  

Mesh：

Year:  2015        PMID： 26384281     DOI： 10.1182/blood-2015-07-655191

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  10 in total

1.  Extranodal NK-T Cell Lymphoma, Nasal Type: Retrospective Analysis of Real-World Data.

Authors:  Sneha J Bothra; Pragya Bhandari; Narendra Agrawal; Narender Tejwani; Rayaz Ahmed; Vishvdeep Khushoo; Sumeet Mirgh; Dinesh Bhurani
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-28       Impact factor: 0.900

2.  Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.

Authors:  Jingwen Wang; Liqiang Wei; Jin Ye; Lei Yang; Xin Li; Jia Cong; Na Yao; Xueying Cui; Yiping Wu; Jing Ding; Le Zhang
Journal:  Int J Hematol       Date:  2017-08-30       Impact factor: 2.490

Review 3.  How we treat NK/T-cell lymphomas.

Authors:  Eric Tse; Wei-Li Zhao; Jie Xiong; Yok-Lam Kwong
Journal:  J Hematol Oncol       Date:  2022-06-03       Impact factor: 23.168

Review 4.  Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature.

Authors:  Xiaotian Wang; Zimu Gong; Shawn Xiang Li; Wei Yan; Yongsheng Song
Journal:  BMC Urol       Date:  2017-09-06       Impact factor: 2.264

Review 5.  The diagnosis and management of NK/T-cell lymphomas.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  J Hematol Oncol       Date:  2017-04-14       Impact factor: 17.388

6.  Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase.

Authors:  Yu Chang; Xiaorui Fu; Zhenchang Sun; Xinli Xie; Ruihua Wang; Zhaoming Li; Xudong Zhang; Guangyao Sheng; Mingzhi Zhang
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

7.  sATP‑binding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.

Authors:  Shaoxuan Wu; Xudong Zhang; Meng Dong; Zhenzhen Yang; Mingzhi Zhang; Qingjiang Chen
Journal:  Oncol Rep       Date:  2020-08-10       Impact factor: 3.906

Review 8.  Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

9.  S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine.

Authors:  Zhiyuan Zhou; Zhaoming Li; Zhenchang Sun; Xudong Zhang; Lisha Lu; Yingjun Wang; Mingzhi Zhang
Journal:  Sci Rep       Date:  2016-03-29       Impact factor: 4.379

Review 10.  NK-/T-cell lymphomas.

Authors:  Hua Wang; Bi-Bo Fu; Robert Peter Gale; Yang Liang
Journal:  Leukemia       Date:  2021-06-11       Impact factor: 11.528
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.